First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data

Author:

Ferraro Laura1ORCID,Quattrone Diego234,La Barbera Daniele1,La Cascia Caterina1,Morgan Craig5,Kirkbride James B6ORCID,Cardno Alastair G7,Sham Pak8,Tripoli Giada19,Sideli Lucia110ORCID,Seminerio Fabio1,Sartorio Crocettarachele1,Szoke Andrei11,Tarricone Ilaria12,Bernardo Miquel13ORCID,Rodriguez Victoria9,Stilo Simona A914,Gayer-Anderson Charlotte5ORCID,de Haan Lieuwe15,Velthorst Eva1617,Jongsma Hannah61718,Bart Rutten B P19,Richards Alexander20ORCID,Arango Celso21,Menezez Paulo Rossi22,Lasalvia Antonio23ORCID,Tosato Sarah23,Tortelli Andrea2425,Del Ben Cristina Marta26,Selten Jean-Paul1827,Jones Peter B28,van Os Jim91929,Di Forti Marta123,Vassos Evangelos23ORCID,Murray Robin M139,

Affiliation:

1. Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), Psychiatry Section, University of Palermo , Palermo , Italy

2. Department of Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London , London , UK

3. National Institute for Health Research, Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College , London , UK

4. South London and Maudsley Mental Health NHS Trust , London , UK

5. Department of Health Service and Population Research, Institute of Psychiatry, King’s College London , London , UK

6. Division of Psychiatry, University College London, Psylife Group , London , UK

7. Division of Psychological and Social Medicine, University of Leeds , Leeds , UK

8. Li KaShing Faculty of Medicine, The University of Hong Kong, Centre for Genomic Sciences , Hong Kong , China

9. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London , London , UK

10. LUMSA University, Department of Human Science , Rome

11. University of Paris Est Creteil, INSERM, IMRB, AP-HP, Hôpitaux Universitaires, H. Mondor, DMU IMPACT , F-94010 Creteil , France

12. Department of Medical and Surgical Science, Psychiatry Unit, Alma Mater Studiorum, University of Bologna , Bologna , Italy

13. Department of Medicine, IDIBAPS, CIBERSAM, Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona , Barcelona , Spain

14. Department of Mental Health and Addiction Services, ASP Crotone , Crotone , Italy

15. Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam , Amsterdam , The Netherlands

16. Department of Psychiatry and Seaver Center for Research and Treatment, Icahn School of Medicine at Mount Sinai , New York, NY , USA

17. Center for Transcultural Psychiatry Veldzicht , Balkbrug, Overijssel , The Netherlands

18. University Centre for Psychiatry, University Medical Centre Groningen , Groningen , The Netherlands

19. Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University , Maastricht , The Netherlands

20. Division of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University , Cardiff , UK

21. Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, School of Medicine, Universidad Complutense de Madrid , Madrid , Spain

22. Department of Preventive Medicine, Faculdade de Medicina, Universidade de São Paulo , São Paulo , Brazil

23. Section of Psychiatry, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona , Verona , Italy

24. Institut Mondor de recherché biomedicale , Creteil , France

25. Etablissement Public de Sante Maison Blanche , Paris , France

26. Neuroscience and Behaviour Department, Ribeirão Preto Medical School, University of São Paulo , Brazil

27. Rivierduinen Institute for Mental Health Care , Leiden , The Netherlands

28. Department of Psychiatry, University of Cambridgeshire and Peterborough NHS Foundation Trust, CAMEO Early Intervention Service , Cambridge , UK

29. UMC Utrecht Brain Centre Rudolf Magnus, Utrecht University , Utrecht , The Netherlands

Abstract

Abstract Cluster studies identified a subgroup of patients with psychosis whose premorbid adjustment deteriorates before the onset, which may reflect variation in genetic influence. However, other studies reported a complex relationship between distinctive patterns of cannabis use and cognitive and premorbid impairment that is worthy of consideration. We examined whether: (1) premorbid social functioning (PSF) and premorbid academic functioning (PAF) in childhood and adolescence and current intellectual quotient (IQ) define different clusters in 802 first-episode of psychosis (FEP) patients; resulting clusters vary in (2) polygenic risk scores (PRSs) for schizophrenia (SCZ_PRS), bipolar disorder (BD_PRS), major depression (MD_PRS), and IQ (IQ_PRS), and (3) patterns of cannabis use, compared to 1,263 population-based controls. Four transdiagnostic clusters emerged (BIC = 2268.5): (1) high-cognitive-functioning (n = 205), with the highest IQ (Mean = 106.1, 95% CI: 104.3, 107.9) and PAF, but low PSF. (2) Low-cognitive-functioning (n = 223), with the lowest IQ (Mean = 73.9, 95% CI: 72.2, 75.7) and PAF, but normal PSF. (3) Intermediate (n = 224) (Mean_IQ = 80.8, 95% CI: 79.1, 82.5) with low-improving PAF and PSF. 4) Deteriorating (n = 150) (Mean_IQ = 80.6, 95% CI: 78.5, 82.7), with normal-deteriorating PAF and PSF. The PRSs explained 7.9% of between-group membership. FEP had higher SCZ_PRS than controls [F(4,1319) = 20.4, P < .001]. Among the clusters, the deteriorating group had lower SCZ_PRS and was likelier to have used high-potency cannabis daily. Patients with FEP clustered according to their premorbid and cognitive abilities. Pronounced premorbid deterioration was not typical of most FEP, including those more strongly predisposed to schizophrenia, but appeared in a cluster with a history of high-potency cannabis use.

Funder

Seventh Framework Programme

Fundacion de Amparo . Pesquisa do Estado de Sao Paulo

National Institute for Health and Care Research

Maudsley Biomedical Research Centre

South London and Maudsley NHS Foundation Trust

King’s College, London, UK

Publisher

Oxford University Press (OUP)

Subject

Psychiatry and Mental health

Reference81 articles.

1. Neuropsychological functioning in first-episode schizophrenia;Kravariti;Br J Psychiatry.,2009

2. Neurocognitive subtypes in patients with bipolar disorder and their unaffected siblings;Russo;Psychol Med.,2017

3. Clusters, dimensions, and hierarchies: finding a path forward for the neuroscience of mental disorders?;Carter;Biol Psychiatry Cogn Neurosci Neuroimaging.,2018

4. Characterising the structure of cognitive heterogeneity in schizophrenia spectrum disorders. A systematic review and narrative synthesis;Carruthers;Neurosci Biobehav Rev.,2019

5. A systematic review of studies reporting data-driven cognitive subtypes across the psychosis spectrum;Green;Neuropsychol Rev.,2020

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3